To further support the proposal that the decrease of cell number was due to the decline of proliferation ability, we looked at the association of the CKAP2L versus two common proliferation biomarkers in the TCGA and CGGA datasets, including MKI67 and MCM6, often used in brain tumor studies [25,26,27]. The gene discussed is CKAP2L; the disease is brain neoplasm.